Prosecution Insights
Last updated: November 04, 2026

Key Medical Technologies Inc.

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Key Medical Technologies Inc. currently manages 1 pending office action within the Chemistry & Materials technology area. This single action represents the current scope of the company's active patent prosecution before the USPTO. The focus on Chemistry & Materials suggests that the company's intellectual property efforts are concentrated within this specific technical domain at this time.

The portfolio's activity is limited to 1 distinct examiner and 1 distinct art unit. This concentration indicates a highly centralized review process, where the entirety of the company's pending workload is subject to the oversight of a single individual within one technical department. For the practitioner, this structure simplifies the administrative management of the portfolio as there are no competing examiner requirements to balance.

Alicia Bland is identified as the busiest examiner for the company, with 1 pending office action. Since there is only 1 pending office action in total, this examiner is the sole point of contact for the company's current USPTO matters. Success in this portfolio depends on navigating the specific preferences and prior art interpretations of this one examiner to effectively advance the company's patent interests.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BLAND, ALICIA 1 50.8% +12.9%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18047865 BIOACTIVE POLYMERS FOR OPHTHALMIC APPLICATIONS BLAND, ALICIA 11d overdue

Top Art Units

Art UnitApps
1759 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18047865 BIOACTIVE POLYMERS FOR OPHTHALMIC APPLICATIONS BLAND, ALICIA 1759 §102 Final Rejection 11d overdue Pending Oct 19, 2022

Managing Key Medical Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Key Medical Technologies Inc. have?

Key Medical Technologies Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Key Medical Technologies Inc. applications?

Alicia Bland has the most, with 1 of Key Medical Technologies Inc.'s pending office actions.

What technology area are Key Medical Technologies Inc.'s patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month